This renewal application of the Rochester Alzheimer Disease Project (RADP), focuses its efforts on one of the originally proposed themes of our program: Failed Neuroplasticity-a possible pathophysiological mechanism of Alzheimer's Disease. The present renewal has been retitled as """"""""Neuroplasticity in Aging and Dementia"""""""" to more specifically highlight our focus. The RADP seeks to continue its efforts to provide a multidisciplinary Clinical/Neuropathological/Neuroscientific study of Alzheimer's Disease (AD) in order to examine the presence or absence of the plastic response in AD and the potential modulatory factors of this response. The component projects include: CLINICAL CORE- neurologic, psychiatric and general medical assessment will define the disease and its stage; NEUROPATHOLOGY CORE-standard and quantitative examinations will define the presence and degree of Alzheimer change; PROJECT ONE-Quantitative study of dendrites in Aging and Dementia will define the presence or absence of age-related dendritic growth in cortex and hippocampus; PROJECT TWO-Quantitative studies of neuronal loss, glial numbers and Growth Associated Protein in AD and Controls will define the hypothesized stimulus for dendritic growth and associated trophic proteins: PROJECT THREE- Quantitative studies of nucleus basalis and locus coeruleus will define cholinergic and noradrenergic neurons in dementia and aging and their potential contribution to the plastic response; PROJECT FOUR-Quantitative assessment of presynaptic and postsynaptic neuro-chemical pathology in AD and Controls will determine neurochemical plasticity as well as the role of these transmitter systems in dendritic plasticity; PROJECT FIVE- Quantitative studies of NGF message and NGF Receptor message will provide new data on the role of this trophic systems in Aging, Dementia and Neuroplasticity. Viewed as a whole, the three cores and five projects are now tightly focused on one main theme: Failed Neuroplasticity-a possible pathophysiological mechansism in AD. The combined multidisciplinary talents of the group will hopefully contribute a unique and more novel approach to the study of plasticity in aging and dementia.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG003644-06
Application #
3090694
Study Section
Aging Review Committee (AGE)
Project Start
1984-04-01
Project End
1992-12-31
Budget Start
1990-04-01
Budget End
1990-12-31
Support Year
6
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Rochester
Department
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Slemmon, J R; Wengenack, T M; Flood, D G (1997) Profiling of endogenous peptides as a tool for studying development and neurological disease. Biopolymers 43:157-70
Kazee, A M; Cox, C; Richfield, E K (1995) Substantia nigra lesions in Alzheimer disease and normal aging. Alzheimer Dis Assoc Disord 9:61-7
Maguire-Zeiss, K A; Li, Z W; Shimoda, L M et al. (1995) Calbindin D28k mRNA in hippocampus, superior temporal gyrus and cerebellum: comparison between control and Alzheimer disease subjects. Brain Res Mol Brain Res 30:362-6
Wetzel, D M; Bohn, M C; Kazee, A M et al. (1995) Glucocorticoid receptor mRNA in Alzheimer's diseased hippocampus. Brain Res 679:72-81
Flood, D G (1994) Thoughts on no neocortical neuronal loss but loss of volume in AD. Neurobiol Aging 15:363-5;discussion 379-80
Slemmon, J R; Hughes, C M; Campbell, G A et al. (1994) Increased levels of hemoglobin-derived and other peptides in Alzheimer's disease cerebellum. J Neurosci 14:2225-35
Wetzel, D M; Bohn, M C; Hamill, R W (1994) Postmortem stability of mRNA for glucocorticoid and mineralocorticoid receptor in rodent brain. Brain Res 649:117-21
Jette, N; Cole, M S; Fahnestock, M (1994) NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients. Brain Res Mol Brain Res 25:242-50
Benesch, C G; McDaniel, K D; Cox, C et al. (1993) End-stage Alzheimer's disease. Glasgow Coma Scale and the neurologic examination. Arch Neurol 50:1309-15
Kazee, A M; Eskin, T A; Lapham, L W et al. (1993) Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria. Alzheimer Dis Assoc Disord 7:152-64

Showing the most recent 10 out of 38 publications